ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,636Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 315

$658K Total Retail Price of All Prescriptions

Rank: 38 out of 315

370 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 370 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

9% of this provider’s 370 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 9,830 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
SIMVASTATIN 627 568 1 1
AMLODIPINE BESYLATE 551 510 2 2
OMEPRAZOLE 380 318 3 9
PRAVASTATIN SODIUM 376 364 4 10
ALENDRONATE SODIUM 359 344 5 12
METFORMIN HCL 333 319 6 7
NEXIUM 255 255 7 54
ATORVASTATIN CALCIUM 252 246 8 5
LOVASTATIN 205 192 9 8
TAMSULOSIN HCL 202 202 10 21
LEVOTHYROXINE SODIUM 193 172 11 6
LOSARTAN POTASSIUM 173 148 12 4
DIOVAN 169 169 13 27
DIOVAN HCT 168 168 14 56
CELEBREX 167 162 15 34
LIDODERM 163 163 16 76
CRESTOR 158 140 17 24
LISINOPRIL 151 134 18 3
GLIPIZIDE 149 127 19 30
PANTOPRAZOLE SODIUM 137 137 20 35
FELODIPINE ER 127 123 21 23
ZOLPIDEM TARTRATE 123 114 22 29
METOPROLOL SUCCINATE 112 98 23 13
JANUMET 109 97 24 83
AMLODIPINE BESYLATE-BENAZEPRIL 108 108 25 26
HYDROCHLOROTHIAZIDE 106 99 26 16
LOVAZA 100 100 27 64
TRAMADOL HCL-ACETAMINOPHEN 97 77 28 123
FLUTICASONE PROPIONATE 96 86 29 53
GLIMEPIRIDE 94 94 30 32
RANITIDINE HCL 93 90 31 42
DONEPEZIL HCL 91 91 32 28
AMOXICILLIN 90 76 33 65
AZITHROMYCIN 88 79 34 39
LOSARTAN-HYDROCHLOROTHIAZIDE 88 88 34 17
PREDNISONE 84 75 36 41
FINASTERIDE 83 83 37 60
ACTONEL 80 80 38 47
CARVEDILOL 80 80 38 22
GABAPENTIN 79 64 40 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 78 75 41 50
ATELVIA 77 77 42 102
PLAVIX 76 76 43 40
CLOPIDOGREL 75 75 44 25
TRAMADOL HCL 72 58 45 59
IBANDRONATE SODIUM 69 65 46 203
HYDROCODONE-ACETAMINOPHEN 67 33 S3 47 19
WARFARIN SODIUM 66 66 48 20
TRIAMCINOLONE ACETONIDE 65 58 49 62
ADVAIR DISKUS 56 55 50 46
EVISTA 54 51 51 48
FUROSEMIDE 53 53 52 15
VALSARTAN-HYDROCHLOROTHIAZIDE 53 53 52 213
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 7, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.